Omnicell (OMCL) Tops Q1 EPS by 13c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Omnicell (OMCL) Tops Q1 EPS by 13c, Revenues Beat

Omnicell Reports First Quarter 2020 Results

May 7, 2020 4:01 PM EDT

GAAP and non-GAAP revenues of $229.7 million, up 13.4% year-over-year
GAAP net income per diluted share of $0.26, up 225.0% year-over-year
Non-GAAP net income per diluted share of $0.66, up 8.2% year-over-year
Omnicells Response to Coronavirus (COVID-19)

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its first quarter ended March 31, 2020.

GAAP Results

GAAP revenues for the first quarter of 2020 were $229.7 million, up $27.2 million, or... More